US Patent 7531304 Method for screening FGFR-4 agonists
All edits
Edits on 17 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Axel Ullrich0
Johannes Bange0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+495 characters)
Article
Patent abstract
The present invention relates to the use of Fibroblast-Growth Factor Receptor (FGFR) agonists for the diagnosis, prevention and/or treatment of pathological conditions including, but not limited to hyperproliferative disorders, bone diseases and vascular diseases. Particularly, the use of FGFR-4 agonists, e.g. anti-FGFR-4 antibodies is described. Further, the invention relates to a pharmaceutical composition comprising the agonist as described above and a screening procedure.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07531304 Method for screening FGFR-4 agonists US Patent 7531304 Method for screening FGFR-4 agonists
Infobox
Patent Number
07531304
Patent Number
7531304
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07531304 Method for screening FGFR-4 agonists
Infobox
Is a
Patent jurisdiction
Patent number
07531304
Date of patent
May 12, 2009
Patent application number
10503242
Date Filed
January 30, 2003
Patent primary examiner
Find more entities like US Patent 7531304 Method for screening FGFR-4 agonists
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
